Price target
25.440.000.00%
The 14 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.
Analyst rating
Based on 16 analysts giving stock ratings in the past 3 months.
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise
This is not investment advice and doesn't take into account your personal circumstances. It isn't a recommendation to buy, sell, or hold any asset. See the Terms of Use and always do your own research.
Frequently asked questions
The current price of TLX is 17.85 AUD — it has increased by 2.29% in the past 24 hours. Watch Telix Pharmaceuticals Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange Telix Pharmaceuticals Limited stocks are traded under the ticker TLX.
TLX stock has risen by 8.51% compared to the previous week, the month change is a 6.50% rise, over the last year Telix Pharmaceuticals Limited has showed a 28.23% increase.
We've gathered analysts' opinions on Telix Pharmaceuticals Limited future price: according to them, TLX price has a max estimate of 31.16 AUD and a min estimate of 19.11 AUD. Watch TLX chart and read a more detailed Telix Pharmaceuticals Limited stock forecast: see what analysts think of Telix Pharmaceuticals Limited and suggest that you do with its stocks.
TLX stock is 3.77% volatile and has beta coefficient of 1.02. Track Telix Pharmaceuticals Limited stock price on the chart and check out the list of the most volatile stocks — is Telix Pharmaceuticals Limited there?
Today Telix Pharmaceuticals Limited has the market capitalization of 6.07 B, it has decreased by −1.42% over the last week.
Yes, you can track Telix Pharmaceuticals Limited financials in yearly and quarterly reports right on TradingView.
Telix Pharmaceuticals Limited is going to release the next earnings report on Feb 19, 2027. Keep track of upcoming events with our Earnings Calendar.
TLX earnings for the last half-year are 0.16 AUD per share, whereas the estimation was 0.06 AUD, resulting in a 140.27% surprise. The estimated earnings for the next half-year are −0.03 AUD per share. See more details about Telix Pharmaceuticals Limited earnings.
Telix Pharmaceuticals Limited revenue for the last half-year amounts to 689.52 M AUD, despite the estimated figure of 693.32 M AUD. In the next half-year revenue is expected to reach 695.90 M AUD.
TLX net income for the last half-year is 54.56 M AUD, while the previous report showed −7.38 M AUD of net income which accounts for 0.00% change. Track more Telix Pharmaceuticals Limited financial stats to get the full picture.
No, TLX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 20, 2026, the company has 1.18 K employees. See our rating of the largest employees — is Telix Pharmaceuticals Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Telix Pharmaceuticals Limited EBITDA is 45.18 M AUD, and current EBITDA margin is 4.92%. See more stats in Telix Pharmaceuticals Limited financial statements.
Like other stocks, TLX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Telix Pharmaceuticals Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Telix Pharmaceuticals Limited technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Telix Pharmaceuticals Limited stock shows the buy signal. See more of Telix Pharmaceuticals Limited technicals for a more comprehensive analysis.